FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS

被引：0

作者：

Gugliotta, G. ^{[1
]}

Castagnetti, F. ^{[1
]}

Breccia, M. ^{[2
]}

Levato, L. ^{[3
]}

Fava, C. ^{[4
]}

Luciano, L. ^{[5
]}

Zaccaria, A. ^{[6
]}

Rossi, A. Russo ^{[7
]}

Usala, E. ^{[8
,9
]}

Gozzini, A. ^{[10
]}

Vigneri, P. ^{[11
]}

Cedrone, M. ^{[12
]}

Tiribelli, M. ^{[13
,14
]}

Abruzzese, E. ^{[15
]}

Avanzini, P. ^{[16
]}

Palandri, F. ^{[1
]}

Soverini, S. ^{[1
]}

Alimena, G. ^{[2
]}

Pane, F. ^{[5
]}

Martinelli, G. ^{[1
]}

Cavo, M. ^{[1
]}

Saglio, G. ^{[4
]}

Baccarani, M. ^{[17
]}

Rosti, G. ^{[1
]}

机构：

[1] Univ Bologna, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[2] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy

[3] Azienda Osped Pugliese Ciaccio, Dept Hematol, Catanzaro, Italy

[4] Univ Turin, San Luigi Gonzaga Hosp, Div Internal Med Hematol, Turin, Italy

[5] Univ Naples Federico II, Dept Hematol CEINGE & Adv Biotechonolgies, Naples, Italy

[6] IRST IRCCS, Hematol Unit, Meldola, Forli Cesena, Italy

[7] Univ Bari, Dept Emergency & Organ Transplantat, Hematol Unit, Bari, Italy

[8] Armando Businco Hosp, Cagliari, Italy

[9] Armando Businco Hosp, Bone Marrow Transplantat Unit, Cagliari, Italy

[10] Univ Florence, Careggi Hosp, Dept Hematol, Florence, Italy

[11] Univ Catania, Ferrarotto Hosp, Div Hematol, Catania, Italy

[12] San Giovanni Hosp, Hematol Unit, Rome, Italy

[13] Univ Udine, Dept Expt & Clin Med Sci, Div Hematol, I-33100 Udine, Italy

[14] Univ Udine, Dept Expt & Clin Med Sci, I-33100 Udine, Italy

[15] S Eugenio Hosp, Dept Hematol, Rome, Italy

[16] Santa Maria Nuova Hosp, Hematol Unit, Reggio Emilia, Italy

[17] Univ Bologna, Bologna, Italy

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P892

引用

页码：333 / 333

页数：1

共 50 条

[1] Five-Year Outcome of 215 Newly Diagnosed Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib-Based Regimens: A Gimema CML Working Party Analysis
Gugliotta, Gabriele
Castagnetti, Fausto
Breccia, Massimo
Levato, Luciano
Rege-Cambrin, Giovanna
Luciano, Luigiana
Bocchia, Monica
Rossi, Antonella Russo
Usala, Emilio
Salvucci, Marzia
Gozzini, Antonella
Binotto, Gianni
Cedrone, Michele
Abruzzese, Elisabetta
Avanzini, Paolo
Venturi, Claudia
Testoni, Nicoletta
Soverini, Simona
Alimena, Giuliana
Cavo, Michele
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2014, 124 (21)
[2] Outcome of 472 Chronic Myeloid Leukemia Patients Treated with Frontline Nilotinib: A Gimema CML WP Analysis
Gugliotta, Gabriele
Castagnetti, Fausto
Breccia, Massimo
Iurlo, Alessandra
D'Adda, Mariella
Stagno, Fabio
Levato, Luciano
Martino, Bruno
Lunghi, Francesca
Tiribelli, Mario
Cambrin, Giovanna Rege
Abruzzese, Elisabetta
Rupoli, Serena
Gozzini, Antonella
Pregno, Patrizia
Salvucci, Marzia
Trabacchi, Elena
Caocci, Giovanni
Scortechini, Anna Rita
Luciano, Luigia
Tagariello, Giuseppe
Bonifacio, Massimiliano
Soverini, Simona
Foa, Robin
Martinelli, Giovanni
Cavo, Michele
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2018, 132
[3] Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party
Gugliotta, Gabriele
Castagnetti, Fausto
Palandri, Francesca
Breccia, Massimo
Intermesoli, Tamara
Capucci, Adele
Martino, Bruno
Pregno, Patrizia
Rupoli, Serena
Ferrero, Dario
Gherlinzoni, Filippo
Montefusco, Enrico
Bocchia, Monica
Tiribelli, Mario
Pierri, Ivana
Grifoni, Federica
Marzocchi, Giulia
Amabile, Marilina
Testoni, Nicoletta
Martinelli, Giovanni
Alimena, Giuliana
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2011, 117 (21) : 5591 - 5599
[4] SECOND MALIGNANCIES IN 559 PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB FRONTLINE: DATA FROM THE GIMEMA CML WORKING PARTY
Gugliotta, G.
Castagnetti, F.
Palandri, F.
Breccia, M.
Radaelli, F.
Capucci, A.
Cavazzini, F.
Ferrero, D.
Stagno, F.
Gherlinzoni, F.
Di Lorenzo, R.
Leoni, P.
Cambrin, G. Rege
Ferrara, F.
Alimena, G.
Martinelli, G.
Pane, F.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 337 - 337
[5] IMPACT OF AGE ON EFFICACY, SAFETY, AND LONG-TERM OUTCOME OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED IN FIRST-LINE WITH NILOTINIB: A GIMEMA CML WORKING PARTY ANALYSIS
Gugliotta, G.
Castagnetti, F.
Breccia, M.
D'Adda, M.
Stagno, F.
Levato, L.
Carella, A. M.
Martino, B.
Tiribelli, M.
Rege-Cambrin, G.
Gozzini, A.
Salvucci, M.
Cedrone, M.
Trabacchi, E.
Usala, E.
Scortechini, A. R.
Luciano, L.
Soverini, S.
Foa, R.
Cavo, M.
Martinelli, G.
Pane, F.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2017, 102 : 85 - +
[6] IMPACT OF ARTERIAL THROMBOTIC EVENTS ON THE LONG-TERM OUTCOME OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED IN FIRST-LINE WITH NILOTINIB: AN ANALYSIS OF THE GIMEMA CML WORKING PARTY
Gugliotta, G.
Castagnetti, F.
Breccia, M.
D'Adda, M.
Stagno, F.
Levato, L.
Carella, A. M.
Martino, B.
Tiribelli, M.
Rege-Cambrin, G.
Gozzini, A.
Salvucci, M.
Cedrone, M.
Trabacchi, E.
Usala, E.
Scortechini, A. R.
Luciano, L.
Soverini, S.
Cavo, M.
Martinelli, G.
Pane, F.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2017, 102 : 237 - 238
[7] Impact of Age on Efficacy, Safety, and Long-Term Outcome of Chronic Myeloid Leukemia (CML) Patients Treated in First-Line with Nilotinib: An Analysis of the Gimema CML Working Party
Gugliotta, Gabriele
Castagnetti, Fausto
Breccia, Massimo
D'Adda, Mariella
Stagno, Fabio
Levato, Luciano
Carella, Angelo Michele
Martino, Bruno
Tiribelli, Mario
Cambrin, Giovanna Rege
Gozzini, Antonella
Salvucci, Marzia
Cedrone, Michele
Trabacchi, Elena
Usala, Emilio
Scortechini, Anna Rita
Luciano, Luigia
Soverini, Simona
Alimena, Giuliana
Cavo, Michele
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2016, 128 (22)
[8] Incidence and Mortality of Second Malignancies In 559 Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib Frontline: Data From the GIMEMA CML Working Party.
Gugliotta, Gabriele
Castagnetti, Fausto
Palandri, Francesca
Breccia, Massimo
Cavazzini, Francesco
Di Lorenzo, Roberto
Levato, Luciano
Girasoli, Mariella
Leone, Giuseppe
Abruzzese, Elisabetta
Tiribelli, Mario
Meneghini, Vittorio
Galieni, Piero
Trabacchi, Elena
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2010, 116 (21) : 939 - 940
[9] Nilotinib 800 Mg Daily as Frontline Therapy of Ph plus Chronic Myeloid Leukemia: Dose Delivered and Safety Profile for the GIMEMA CML Working Party
Rosti, Gianantonio
Castagnetti, Fausto
Palandri, Francesca
Breccia, Massimo
Levato, Luciano
Gugliotta, Gabriele
Capucci, Adele
Cedrone, Michele
Fava, Carmen
Intermesoli, Tamara
Cambrin, Giovanna Rege
Stagno, Fabio
Tiribelli, Mario
Amabile, Marilina
Luatti, Simona
Poerio, Angela
Soverini, Simona
Testoni, Nicoletta
Alimena, Giuliana
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Martinelli, Giovanni
BLOOD, 2009, 114 (22) : 868 - 868
[10] Frontline Treatment With Imatinib Mesylate in Chronic Myeloid Leukemia Patients in Early Chronic Phase: a Very Long-Term Analysis by the GIMEMA CML Working Party
Castagnetti, Fausto
Gugliotta, Gabriele
Breccia, Massimo
Specchia, Giorgina
Intermesoli, Tamara
Capucci, Adele
Martino, Bruno
Tiribelli, Mario
Binotto, Gianni
Abruzzese, Elisabetta
Stagno, Fabio
Leoni, Pietro
Ferrero, Dario
Gherlinzoni, Filippo
Palandri, Francesca
Venturi, Claudia
Bochicchio, Maria Teresa
Soverini, Simona
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Cavo, Michele
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →